All News

As respiratory virus season approaches, misinformation threatens lives; understanding vaccines is crucial for protecting our communities and future.

As various regions across the country experience snowstorms, pharmacies must be proactive about ensuring minimal disruptions to their operations.

The Pharmacy Quality Alliance enhances patient outcomes by addressing social determinants of health through effective community partnerships and pharmacist involvement.

During the week of Roe v Wade’s 53rd anniversary, debates between pro-choice and pro-life groups are yet again reaching the national stage.

GLP-1 therapies gain popularity, but patient adherence struggles due to fragmented support and emotional barriers.

Natalie DiPietro Mager, PharmD, PhD, explores some of the policies that have bolstered maternal health care and what can still be done to further improve patient outcomes.

Amid evolving recommendations for products like acetaminophen as well as influenza vaccines, researchers revisit the role of pharmacists in addressing adolescents’ cold and flu symptoms.

The new provisions would be the first major update to a Medicare Part D statute impacting the pharmacy industry in nearly 20 years.

Alongside the global pharma market, OTC supplements are expected to experience over a 6% compound annual growth rate for the next 5-plus years.

Medical organizations challenge the government's revised childhood vaccine schedule, urging Congress for immediate oversight and action to protect public health.

Lumateperone shows promising remission rates for major depressive disorder, offering hope for sustained relief in adults when combined with antidepressants.

Pharmacists address the hidden risks of legal substances like nitrous oxide and kratom, emphasizing the need for public education and safety measures.

Fremanezumab significantly reduces migraine days in children and adolescents, offering a vital preventive option for managing episodic migraines.

Gestational diabetes significantly impacts postpartum cardiovascular health, especially in women over 35, highlighting the need for timely interventions.

Focused on lowering costs and saving patients money, the plan is focused on drug prices, insurance premiums, and some of health care’s largest companies.

This marks the disease’s very first treatment option for pediatric patients looking to manage Menkes and its symptoms.

The current understanding regarding artificial intelligence (AI) in pharmacy curricula is necessary to equip future pharmacists with advanced technological knowledge.

Educational interventions and pharmacist engagement enhance patient safety in OTC medication use, addressing knowledge gaps and promoting responsible self-care practices.

Mavacamten shows promise in treating adolescent obstructive hypertrophic cardiomyopathy, significantly improving heart function and safety in a pivotal trial.

A group of researchers conducts 3 focus groups centered on community pharmacies in Colorado and Utah and the impact of their closures.

Meagan Brown, PharmD, BCACP, discusses the nuances of pharmacists’ provider status and its evolution within the greater health care community.

Addressing the lack of evidence regarding pharmacists’ roles as immunization authorities on infant respiratory syncytial virus (RSV) vaccines.

Following approval in 2023, researchers address lessons learned from the coalition- and movement-driven efforts to approve the first OTC oral contraceptive pill.

Pharmacists received surveys to quantify their usage of collaborative practice agreements among community pharmacies in Ohio.

Pharmacists play a crucial role in preventing OTC drug abuse through proactive interventions and effective warning measures, according to recent research findings.

Pharmacy staff's confidence in the Senior Safe's effectiveness was the key factor leading to the success of managing OTC medication misuse among older adults.

US adults were surveyed about their understanding of shared clinical decision-making following the HHS overhaul of childhood vaccines.

GSK announces promising phase 3 trial results for bepirovirsen, a potential treatment for chronic hepatitis B, showing significant functional cure rates.